Tylenol’s manufacturer moved Thursday to clarify a resurfaced 2017 social media post after the Trump administration cited it in support of claims that acetaminophen use during pregnancy could be linked to autism.
The Department of Health and Human Services pointed to the years-old post, in which Tylenol’s account wrote, “We don’t actually recommend using any of our products while pregnant.” This followed Donald Trump and health officials announcing new guidance against acetaminophen for pregnant women, despite a lack of causal evidence.
Manufacturer Kenvue said the post was “taken out of context,” explaining that the company does not give medical advice on pregnancy and defers to health providers. “Our guidance on the safe use of Tylenol has not changed,” it said, adding that the original post was part of a deleted thread.
Medical groups, including the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, continue to affirm acetaminophen’s safety. SMFM said recent studies suggesting possible risks show no proven causal link to autism or ADHD.
Sources:
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
